Cara Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Cara Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $10.39 on 03/03/23, while the lowest value for the same period was recorded at $0.50 on 01/25/24.

52-week price history of CARA Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cara Therapeutics Inc’s current trading price is -92.29% away from its 52-week high, while its distance from the 52-week low is 60.22%. The stock’s price range during this period has spanned from $0.50 to $10.39. In the Healthcare sector, the Cara Therapeutics Inc’s shares surpassed a trading volume of approximately 1.82 million for the day, which was noticeably higher compared to the average daily volume of 9.0.87 million over the past three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Market Capitalization and Financial Performance: An In-Depth Look

Cara Therapeutics Inc (CARA) has experienced a quarterly decline of -16.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 43.64M and boasts a workforce of 106 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9399, with a change in price of -0.8389. Similarly, Cara Therapeutics Inc recorded 730,145 in trading volume during the last 100 days, posting a change of -51.15%.

Examining CARA’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CARA stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.08.

CARA Stock Stochastic Average

Today’s raw stochastic average for Cara Therapeutics Inc over the last 50 days is 37.17%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 46.52%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 69.96% and 80.02%, respectively.

CARA Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 7.82%.However, over the last six months, we can see a stronger performance of -71.89%. Over the last 30 days, the price of CARA has fallen by 41.89%. And in the last five days, it has surged by 27.93%.

On Key

Related Posts